| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.9M | +74.3% |
| Cost of Revenue | $427K | +114.0% |
| Gross Profit | $3.5M | +70.4% |
| R&D Expense | $1.6M | — |
| SG&A Expense | $2.5M | +619.9% |
| Operating Income | $971K | -42.6% |
| Interest Expense | -$4K | — |
| Pre-tax Income | $559K | -67.0% |
| Income Tax | $172K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $104K | -27.5% |
| Accounts Receivable | $1.3M | +18.9% |
| Inventory | $226K | — |
| Current Assets | $5.9M | +69.6% |
| Total Assets | $7.9M | +37.5% |
| Current Liabilities | $3.4M | +123.1% |
| Total Liabilities | $3.4M | +121.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$83K | -141.1% |
| Investing Cash Flow | -$312K | -84.7% |
| Financing Cash Flow | $396K | — |
| -63.6% |
| Net Income | $386K | -68.3% |
| EPS (Basic) | $0.00 | -67.8% |
| EPS (Diluted) | $0.00 | -52.5% |
| Stockholders' Equity |
| $4.5M |
| +6.7% |